Cargando…
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113028/ https://www.ncbi.nlm.nih.gov/pubmed/30142872 http://dx.doi.org/10.1097/MD.0000000000012163 |
Ejemplares similares
-
Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma
por: Peng, Haiying, et al.
Publicado: (2018) -
Circ-DLG 1 promotes the proliferation of esophageal squamous cell carcinoma [Erratum]
Publicado: (2018) -
Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2017) -
Erratum to the association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer
Publicado: (2022) -
Phosphoglycerate Mutase 1 Predicts the Poor Prognosis of Oral Squamous Cell Carcinoma and is Associated with Cell Migration - Erratum
por: Zhang, Dadong, et al.
Publicado: (2020)